Stocks · News reference
Sensus Healthcare Reports Q2 2026 Financial Results and Analyst Rating Update
Sensus Healthcare reported a decline in revenue and an adjusted net loss for the second quarter of 2026, while Lake Street adjusted its price target for the company.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- fiscal.ai
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Sensus Healthcare Shares Halted On Circuit Breaker, Stock Now Up 30.18%
Sensus Healthcare to Report Third Quarter 2026 Financial Results on November 12, 2026
Sensus Healthcare, Inc. announced it will release its financial results for the third quarter of 2026 on November 12, 2026, followed by a conference call.
Lake Street Maintains Buy on Sensus Healthcare, Lowers Price Target to $4
Lake Street analyst Ben Haynor maintains Sensus Healthcare (NASDAQ:SRTS) with a Buy and lowers the price target from $4.5 to $4.
Applied Materials, Globant And 3 Stocks To Watch Heading Into Friday
U.S. stock futures mixed, investors eye Suncrete Inc's quarterly loss. Applied Materials beats expectations, Bally's Corp to release earnings.
Full Transcript: Sensus Healthcare Q2 2026 Earnings Call
Sensus Healthcare (NASDAQ:SRTS) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. This content is powered by Benzinga APIs. For comprehensive